A Prospective, Monocentric Study Assessing Impact of Posaconazole Prophylaxis on Fungal Colonisation and Invasive Fungal Infections in Patients Receiving Posaconazole Prophylaxis for Graft Versus Host Disease (GVHD) after Hematopoietic Stem Cell Transplantation (HSCT) or Chemotherapy for Acute Myeloid Leukemia (AML)

Trial Profile

A Prospective, Monocentric Study Assessing Impact of Posaconazole Prophylaxis on Fungal Colonisation and Invasive Fungal Infections in Patients Receiving Posaconazole Prophylaxis for Graft Versus Host Disease (GVHD) after Hematopoietic Stem Cell Transplantation (HSCT) or Chemotherapy for Acute Myeloid Leukemia (AML)

Completed
Phase of Trial: Phase II

Latest Information Update: 03 Jul 2017

At a glance

  • Drugs Posaconazole (Primary)
  • Indications Mycoses
  • Focus Pharmacokinetics; Therapeutic Use
  • Most Recent Events

    • 03 Jul 2017 New trial record
    • 05 Jun 2017 Results presented at the ASM Microbe 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top